company background image
BIOM3 logo

Biomm BOVESPA:BIOM3 Stock Report

Last Price

R$8.90

Market Cap

R$1.1b

7D

0%

1Y

109.4%

Updated

20 Oct, 2024

Data

Company Financials

Biomm S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Biomm
Historical stock prices
Current Share PriceR$8.90
52 Week HighR$21.20
52 Week LowR$4.15
Beta0.86
11 Month Change-11.88%
3 Month Change-24.70%
1 Year Change109.41%
33 Year Change-32.73%
5 Year Change2.53%
Change since IPO1,171.43%

Recent News & Updates

Biomm S.A. (BVMF:BIOM3) Investors Are Less Pessimistic Than Expected

Jul 05
Biomm S.A. (BVMF:BIOM3) Investors Are Less Pessimistic Than Expected

Is Biomm (BVMF:BIOM3) Weighed On By Its Debt Load?

May 24
Is Biomm (BVMF:BIOM3) Weighed On By Its Debt Load?

Biomm S.A.'s (BVMF:BIOM3) 69% Price Boost Is Out Of Tune With Revenues

Apr 18
Biomm S.A.'s (BVMF:BIOM3) 69% Price Boost Is Out Of Tune With Revenues

Recent updates

Biomm S.A. (BVMF:BIOM3) Investors Are Less Pessimistic Than Expected

Jul 05
Biomm S.A. (BVMF:BIOM3) Investors Are Less Pessimistic Than Expected

Is Biomm (BVMF:BIOM3) Weighed On By Its Debt Load?

May 24
Is Biomm (BVMF:BIOM3) Weighed On By Its Debt Load?

Biomm S.A.'s (BVMF:BIOM3) 69% Price Boost Is Out Of Tune With Revenues

Apr 18
Biomm S.A.'s (BVMF:BIOM3) 69% Price Boost Is Out Of Tune With Revenues

Biomm S.A.'s (BVMF:BIOM3) Share Price Is Matching Sentiment Around Its Revenues

Feb 21
Biomm S.A.'s (BVMF:BIOM3) Share Price Is Matching Sentiment Around Its Revenues

Biomm (BVMF:BIOM3) Is Making Moderate Use Of Debt

Nov 12
Biomm (BVMF:BIOM3) Is Making Moderate Use Of Debt

We Think Biomm (BVMF:BIOM3) Has A Fair Chunk Of Debt

Jul 25
We Think Biomm (BVMF:BIOM3) Has A Fair Chunk Of Debt

Positive Sentiment Still Eludes Biomm S.A. (BVMF:BIOM3) Following 26% Share Price Slump

Apr 17
Positive Sentiment Still Eludes Biomm S.A. (BVMF:BIOM3) Following 26% Share Price Slump

Biomm (BVMF:BIOM3) Is Making Moderate Use Of Debt

Feb 28
Biomm (BVMF:BIOM3) Is Making Moderate Use Of Debt

Biomm (BVMF:BIOM3) Is Making Moderate Use Of Debt

Oct 15
Biomm (BVMF:BIOM3) Is Making Moderate Use Of Debt

Biomm (BVMF:BIOM3) Is Carrying A Fair Bit Of Debt

Jun 29
Biomm (BVMF:BIOM3) Is Carrying A Fair Bit Of Debt

We Think Biomm (BVMF:BIOM3) Has A Fair Chunk Of Debt

Aug 17
We Think Biomm (BVMF:BIOM3) Has A Fair Chunk Of Debt

Here's Why Biomm (BVMF:BIOM3) Can Afford Some Debt

Apr 05
Here's Why Biomm (BVMF:BIOM3) Can Afford Some Debt

Biomm (BVMF:BIOM3) Shareholders Have Enjoyed An Impressive 173% Share Price Gain

Mar 01
Biomm (BVMF:BIOM3) Shareholders Have Enjoyed An Impressive 173% Share Price Gain

Do Institutions Own Biomm S.A. (BVMF:BIOM3) Shares?

Jan 25
Do Institutions Own Biomm S.A. (BVMF:BIOM3) Shares?

Is Biomm (BVMF:BIOM3) A Risky Investment?

Dec 21
Is Biomm (BVMF:BIOM3) A Risky Investment?

Shareholder Returns

BIOM3BR BiotechsBR Market
7D0%0.9%0.7%
1Y109.4%21.6%9.6%

Return vs Industry: BIOM3 exceeded the BR Biotechs industry which returned 21.6% over the past year.

Return vs Market: BIOM3 exceeded the BR Market which returned 9.6% over the past year.

Price Volatility

Is BIOM3's price volatile compared to industry and market?
BIOM3 volatility
BIOM3 Average Weekly Movement9.4%
Biotechs Industry Average Movement9.2%
Market Average Movement4.4%
10% most volatile stocks in BR Market9.1%
10% least volatile stocks in BR Market2.2%

Stable Share Price: BIOM3's share price has been volatile over the past 3 months compared to the BR market.

Volatility Over Time: BIOM3's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of BR stocks.

About the Company

FoundedEmployeesCEOWebsite
2001130Heraldo Marcheziniwww.biomm.com

Biomm S.A. operates as a biotechnology company in Brazil. The company offers AFREZZA, a human insulin inhalation powder; GHEMAXAN, an enoxaparina sodica; GLARGILIN, a glargine insulin; WOSULIN R, a human insulin; WOSULIN N, an isophane insulin; HERZUMA, a trastuzumab; and CANETA LIFEPEN G PARA APLICACAO DE INSULINA. Biomm S.A. was founded in 2001 and is headquartered in Nova Lima, Brazil.

Biomm S.A. Fundamentals Summary

How do Biomm's earnings and revenue compare to its market cap?
BIOM3 fundamental statistics
Market capR$1.13b
Earnings (TTM)-R$78.35m
Revenue (TTM)R$123.78m

9.1x

P/S Ratio

-14.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOM3 income statement (TTM)
RevenueR$123.78m
Cost of RevenueR$95.84m
Gross ProfitR$27.94m
Other ExpensesR$106.29m
Earnings-R$78.35m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 13, 2024

Earnings per share (EPS)-0.62
Gross Margin22.57%
Net Profit Margin-63.30%
Debt/Equity Ratio43.7%

How did BIOM3 perform over the long term?

See historical performance and comparison